Biodegradable microparticles for sustained release of a new GnRH antagonist – part I: screening commercial PLGA and formulation technologies
- 1 November 2003
- journal article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 56 (3) , 327-336
- https://doi.org/10.1016/s0939-6411(03)00096-1
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- GnRH Antagonists: A New Generation of Long Acting Analogues Incorporatingp-Ureido-phenylalanines at Positions 5 and 6Journal of Medicinal Chemistry, 2000
- Pituitary and gonadal endocrine effects and pharmacokinetics of the novel luteinizing hormone-releasing hormone antagonist teverelix in healthy men-a first-dose-in-humans studyClinical Pharmacology & Therapeutics, 2000
- Development of GnRH Antagonists for Prostate Cancer: New Approaches to TreatmentThe Oncologist, 2000
- Characterization of biodegradable poly(d,l-lactide-co-glycolide) polymers and microspheresPublished by Elsevier ,1999
- Biodegradation and biocompatibility of PLA and PLGA microspheresPublished by Elsevier ,1999
- Something new in the field of PLA/GA bioresorbable polymers?Journal of Controlled Release, 1998
- Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: Release kinetics and stability issuesJournal of Microencapsulation, 1998
- Rational use of agonists and antagonists of luteinizing hormone-releasing hormone (LH-RH) in the treatment of hormone-sensitive neoplasms and gynaecologic conditionsAdvanced Drug Delivery Reviews, 1997
- One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetateAdvanced Drug Delivery Reviews, 1997
- Biodegradable carriers for the sustained release of polypeptidesTrends in Biotechnology, 1987